SEC Form 4 · accession 0001144204-16-104051
Harvard Apparatus Regenerative Technology, Inc. · HRGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas McNaughton
Officer — Chief Financial Officer
Period of report
May 20, 2016
Accepted (ET)
May 23, 2016 · 8:00 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001563665
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 20, 2016 | P | 2,500 | $1.56 | A | 203,628 | D | |
| Common StockF2 | May 20, 2016 | P | 2,500 | $1.55 | A | 206,128 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes (a) a deferred stock award of 268 restricted stock units which vest on January 1, 2017; and (b) 203,360 shares of common stock held by the Reporting Person.
- F2Includes (a) a deferred stock award of 268 restricted stock units which vest on January 1, 2017; and (b) 205,860 shares of common stock held by the Reporting Person.
Remarks
This form has been signed under power of attorney.